← Evidence map

ArticleACS medicinal chemistry letters2025

Discovery of Rezatapopt (PC14586), a First-in-Class, Small-Molecule Reactivator of p53 Y220C Mutant in Development.

Binh T Vu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

31 papers cite it

2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 39811143